SEARCH

SEARCH BY CITATION

References

  • 1
    Bristow MR, Mason JW, Billingham ME, et al . Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med. 1978; 88: 16875.
  • 2
    Steinherz LJ, Steinherz PG, Tan C. Cardiac failure and dysrhythmias 6–19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol. 1995; 24: 35261.
  • 3
    Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998; 339: 9005.
  • 4
    Thompson KL, Rosenzweig BA, Zhang J, et al . Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats. Cancer Chemother Pharmacol. 2010; 66: 30314.
  • 5
    Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 2001; 33: 1897918.
  • 6
    Ferdinandy P, Appelbaum Y, Csonka C, et al . Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts. Clin Exp Pharmacol Physiol. 1998; 25: 496502.
  • 7
    Varga E, Bodi A, Ferdinandy P, et al . The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J Cardiovasc Pharmacol. 1999; 34: 7117.
  • 8
    Xi L, Jarrett NC, Hess ML, et al . Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation. 1999; 99: 215763.
  • 9
    Webb A, Bond R, McLean P, et al . Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA. 2004; 101: 136838.
  • 10
    Cosby K, Partovi KS, Crawford JH, et al . Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003; 9: 1498505.
  • 11
    Bryan NS, Calvert JW, Elrod JW, et al . Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2007; 104: 191449.
  • 12
    Duranski MR, Greer JJ, Dejam A, et al . Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005; 115: 123240.
  • 13
    Tsuchiya K, Kanematsu Y, Yoshizumi M, et al . Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol. 2005; 288: H216370.
  • 14
    Kapil V, Milsom AB, Okorie M, et al . Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension. 2010; 56: 27481.
  • 15
    Zhu SG, Das A, Xi L, et al . Dietary supplementation of nitrate protects against doxorubicin-induced ventricular dysfunction and cardiomyocyte cell death in mice. Circulation. 2008; 118: S945 (abstract).
  • 16
    Chen Q, Zhu SG, Lesnefsky EJ, et al . Chronic dietary supplementation of nitrate prevents doxorubicin-induced cardiac mitochondrial damage. Circulation. 2009; 120: S867 (abstract).
  • 17
    Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem. 2005; 382: 66978.
  • 18
    Moore JC, Fu J, Chan YC, et al . Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun. 2008; 372: 5538.
  • 19
    Koka S, Das A, Zhu SG, et al . Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect. J Pharmacol Exp Ther. 2010; 334: 102330.
  • 20
    Merten KE, Feng W, Zhang L, et al . Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity. J Pharmacol Exp Ther. 2005; 315: 13149.
  • 21
    Yen HC, Oberley TD, Vichitbandha S, et al . The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest. 1996; 98: 125360.
  • 22
    Yen HC, Oberley TD, Gairola CG, et al . Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys. 1999; 362: 5966.
  • 23
    Chen Q, Zhu S-G, Lesnefsky EJ, et al . Chronic dietary supplementation of nitrate decreases doxorubicin-induced oxidative stress in cardiac mitochondria and tissues. Circulation. 2010; 122, A15894 (abstract).
  • 24
    Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005; 38: 154352.
  • 25
    Kang SW, Rhee SG, Chang TS, et al . 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med. 2005; 11: 5718.
  • 26
    Plaisant F, Clippe A, Vander SD, et al . Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radic Biol Med. 2003; 34: 86272.
  • 27
    Banmeyer I, Marchand C, Clippe A, et al . Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett. 2005; 579: 232733.
  • 28
    Trujillo M, Clippe A, Manta B, et al . Pre-steady state kinetic characterization of human peroxiredoxin 5: taking advantage of Trp84 fluorescence increase upon oxidation. Arch Biochem Biophys. 2007; 467: 95106.
  • 29
    Abbas K, Breton J, Picot CR, et al . Signaling events leading to peroxiredoxin 5 up-regulation in immunostimulated macrophages. Free Radic Biol Med. 2009; 47: 794802.
  • 30
    Ito H, Miller SC, Billingham ME, et al . Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci USA. 1990; 87: 42759.
  • 31
    Yi X, Bekeredjian R, DeFilippis NJ, et al . Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol. 2006; 290: H1098102.
  • 32
    Chen Y, Daosukho C, Opii WO, et al . Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice. Free Radic Biol Med. 2006; 41: 14707.
  • 33
    Ohyama K, Tomonari M, Ichibangase T, et al . A toxicoproteomic study on cardioprotective effects of pre-administration of docetaxel in a mouse model of adriamycin-induced cardiotoxicity. Biochem Pharmacol. 2010; 80: 5407.
  • 34
    Vedam K, Nishijima Y, Druhan LJ, et al . Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice. Am J Physiol Heart Circ Physiol. 2010; 298: H183241.
  • 35
    Venkatakrishnan CD, Tewari AK, Moldovan L, et al . Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27. Am J Physiol Heart Circ Physiol. 2006; 291: H268091.
  • 36
    Xie L, Terrand J, Xu B, et al . Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. Cardiovasc Res. 2010; 87: 62835.
  • 37
    Ayebo A, Kross BC, Vlad M, et al . Infant Methemoglobinemia in the Transylvania Region of Romania. Int J Occup Environ Health. 1997; 3: 209.
  • 38
    McKnight GM, Duncan CW, Leifert C, et al . Dietary nitrate in man: friend or foe Br J Nutr. 1999; 81: 34958.
  • 39
    Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009; 90: 110.
  • 40
    Bailey SJ, Winyard P, Vanhatalo A, et al . Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009; 107: 114455.
  • 41
    Larsen FJ, Weitzberg E, Lundberg JO, et al . Dietary nitrate reduces maximal oxygen consumption while maintaining work performance in maximal exercise. Free Radic Biol Med. 2010; 48: 3427.
  • 42
    Carlstrom M, Larsen FJ, Nystrom T, et al . Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci USA. 2010; 107: 1771620.